Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1993 Jan;91(1):12–20. doi: 10.1172/JCI116160

Specificity of T cells invading the skin during acute graft-vs.-host disease after semiallogeneic bone marrow transplantation.

J Gaschet 1, B Mahé 1, N Milpied 1, M C Devilder 1, B Dréno 1, J D Bignon 1, F Davodeau 1, M M Hallet 1, M Bonneville 1, H Vié 1
PMCID: PMC329989  PMID: 8423212

Abstract

The mechanisms responsible for skin lesions during acute graft-vs.-host disease (aGVHD) after allogeneic bone marrow transplantation (BMT) are poorly understood. The exact role of various effector cell populations and "major" (particularly HLA-DP) or "minor" antigens as target molecules is not known. To investigate the nature of cells responsible for tissue injury, we cultured T cells from skin biopsy first with interleukin 2 (IL-2) alone and then in polyclonal activation conditions to avoid in vitro antigenic sensitization before specificity testing. We applied this method to two biopsies performed during aGVHD after semiallogeneic BMT and obtained cytotoxic T cells against four graft mismatches: CD8+ T cells against HLA-A2.2 and HLA-B27 and CD4+ T cells against HLA-DP101 and HLA-DP401. This demonstrates that T cells with documented specificity can be obtained from an aGVHD lesion without antigenic selection. Moreover, these data directly implicate DP as a potential target antigen for aGVHD.

Full text

PDF
14

Images in this article

17Image
on p.17

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atkinson K., Farrelly H., Cooley M., O'Flaherty E., Downs K., Biggs J. Human marrow T cell dose correlates with severity of subsequent acute graft-versus-host disease. Bone Marrow Transplant. 1987 Jun;2(1):51–57. [PubMed] [Google Scholar]
  2. Breathnach S. M., Shimada S., Kovac Z., Katz S. I. Immunologic aspects of acute cutaneous graft-versus-host disease: decreased density and antigen-presenting function of Ia+ Langerhans cells and absent antigen-presenting capacity of Ia+ keratinocytes. J Invest Dermatol. 1986 Mar;86(3):226–234. doi: 10.1111/1523-1747.ep12285176. [DOI] [PubMed] [Google Scholar]
  3. Goulmy E., Gratama J. W., Blokland E., Zwaan F. E., van Rood J. J. A minor transplantation antigen detected by MHC-restricted cytotoxic T lymphocytes during graft-versus-host disease. Nature. 1983 Mar 10;302(5904):159–161. doi: 10.1038/302159a0. [DOI] [PubMed] [Google Scholar]
  4. Guyotat D., Mauduit G., Chouvet B., Kanitakis J., Van H. V., Fiere D., Thivolet J. A sequential study of histological and immunological changes in the skin after allogenic bone marrow transplantation. Transplantation. 1986 Mar;41(3):340–342. doi: 10.1097/00007890-198603000-00011. [DOI] [PubMed] [Google Scholar]
  5. Hale G., Cobbold S., Waldmann H. T cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation. Transplantation. 1988 Apr;45(4):753–759. doi: 10.1097/00007890-198804000-00018. [DOI] [PubMed] [Google Scholar]
  6. Hervé P., Cahn J. Y., Flesch M., Plouvier E., Racadot E., Noir A., Couteret Y., Goldstein G., Bernard A., Lenys R. Successful graft-versus-host disease prevention without graft failure in 32 HLA-identical allogeneic bone marrow transplantations with marrow depleted of T cells by monoclonal antibodies and complement. Blood. 1987 Feb;69(2):388–393. [PubMed] [Google Scholar]
  7. Kasten-Sportès C., Masset M., Varrin F., Devergie A., Gluckman E. Phenotype and function of T lymphocytes infiltrating the skin during graft-versus-host disease following allogeneic bone marrow transplantation. Transplantation. 1989 Apr;47(4):621–624. doi: 10.1097/00007890-198904000-00012. [DOI] [PubMed] [Google Scholar]
  8. Kato Y., Mitsuishi Y., Cecka M., Hopfield J., Hunt L., Champlin R., Terasaki P. I., Gajewski J. L. HLA-DP incompatibilities and severe graft-versus-host disease in unrelated bone marrow transplants. Transplantation. 1991 Aug;52(2):374–376. [PubMed] [Google Scholar]
  9. Kaye V. N., Neumann P. M., Kersey J., Goltz R. W., Baldridge B. D., Michael A. F., Platt J. L. Identity of immune cells in graft-versus-host disease of the skin. Analysis using monoclonal antibodies by indirect immunofluorescence. Am J Pathol. 1984 Sep;116(3):436–440. [PMC free article] [PubMed] [Google Scholar]
  10. Kernan N. A., Collins N. H., Juliano L., Cartagena T., Dupont B., O'Reilly R. J. Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease. Blood. 1986 Sep;68(3):770–773. [PubMed] [Google Scholar]
  11. Kirk A. D., Ibrahim M. A., Bollinger R. R., Dawson D. V., Finn O. J. Renal allograft-infiltrating lymphocytes. A prospective analysis of in vitro growth characteristics and clinical relevance. Transplantation. 1992 Feb;53(2):329–338. doi: 10.1097/00007890-199202010-00014. [DOI] [PubMed] [Google Scholar]
  12. LeFranc M. P., Forster A., Baer R., Stinson M. A., Rabbitts T. H. Diversity and rearrangement of the human T cell rearranging gamma genes: nine germ-line variable genes belonging to two subgroups. Cell. 1986 Apr 25;45(2):237–246. doi: 10.1016/0092-8674(86)90388-0. [DOI] [PubMed] [Google Scholar]
  13. Maraninchi D., Gluckman E., Blaise D., Guyotat D., Rio B., Pico J. L., Leblond V., Michallet M., Dreyfus F., Ifrah N. Impact of T-cell depletion on outcome of allogeneic bone-marrow transplantation for standard-risk leukaemias. Lancet. 1987 Jul 25;2(8552):175–178. doi: 10.1016/s0140-6736(87)90763-x. [DOI] [PubMed] [Google Scholar]
  14. Marrack P., Kappler J. T cells can distinguish between allogeneic major histocompatibility complex products on different cell types. Nature. 1988 Apr 28;332(6167):840–843. doi: 10.1038/332840a0. [DOI] [PubMed] [Google Scholar]
  15. Martin P. J., Hansen J. A., Buckner C. D., Sanders J. E., Deeg H. J., Stewart P., Appelbaum F. R., Clift R., Fefer A., Witherspoon R. P. Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts. Blood. 1985 Sep;66(3):664–672. [PubMed] [Google Scholar]
  16. Minami M., Kawasaki H., Taira S., Nariuchi H. Alloantigen presentation by B cells: two types of alloreactive T cell hybridomas, B cell-reactive and B cell-nonreactive. J Immunol. 1985 Jul;135(1):111–116. [PubMed] [Google Scholar]
  17. Moisan J. P., Bonneville M., Bouyge I., Moreau J. F., Soulillou J. P., Lefranc M. P. Characterization of T-cell-receptor gamma (TRG) gene rearrangements in alloreactive T-cell clones. Hum Immunol. 1989 Feb;24(2):95–110. doi: 10.1016/0198-8859(89)90050-5. [DOI] [PubMed] [Google Scholar]
  18. Nickoloff B. J., Basham T. Y., Merigan T. C., Torseth J. W., Morhenn V. B. Human keratinocyte-lymphocyte reactions in vitro. J Invest Dermatol. 1986 Jul;87(1):11–18. doi: 10.1111/1523-1747.ep12523513. [DOI] [PubMed] [Google Scholar]
  19. Niederwieser D., Auböck J., Troppmair J., Herold M., Schuler G., Boeck G., Lotz J., Fritsch P., Huber C. IFN-mediated induction of MHC antigen expression on human keratinocytes and its influence on in vitro alloimmune responses. J Immunol. 1988 Apr 15;140(8):2556–2564. [PubMed] [Google Scholar]
  20. Noga S. J., Wagner J. E., Rowley S. D., Davis J. M., Vogelsang G. B., Hess A. D., Saral R., Santos G. W., Donnenberg A. D. Using elutriation to engineer bone marrow allografts. Prog Clin Biol Res. 1990;333:345–361. [PubMed] [Google Scholar]
  21. Odum N., Platz P., Jakobsen B. K., Petersen C. M., Jacobsen N., Møller J., Ryder L. P., Lamm L., Svejgaard A. HLA-DP and bone marrow transplantation: DP-incompatibility and severe acute graft versus host disease. Tissue Antigens. 1987 Nov;30(5):213–216. doi: 10.1111/j.1399-0039.1987.tb01624.x. [DOI] [PubMed] [Google Scholar]
  22. Paller A. S., Nelson A., Steffen L., Gottschalk L., Kaizer H. T-lymphocyte subsets in the lesional skin of allogeneic and autologous bone marrow transplant patients. Arch Dermatol. 1988 Dec;124(12):1795–1801. [PubMed] [Google Scholar]
  23. Panina-Bordignon P., Corradin G., Roosnek E., Sette A., Lanzavecchia A. Recognition by class II alloreactive T cells of processed determinants from human serum proteins. Science. 1991 Jun 14;252(5012):1548–1550. doi: 10.1126/science.1710827. [DOI] [PubMed] [Google Scholar]
  24. Parfrey N. A., Ste-Croix H., Prud'Homme G. J. Evidence that nonlymphoid tissue injury in acute graft-versus-host disease is limited to epithelial cells aberrantly expressing MHC antigens. Transplantation. 1989 Oct;48(4):655–660. [PubMed] [Google Scholar]
  25. Pawelec G., Ehninger G., Schmidt H., Wernet P. HLA-DP matching and graft-versus-host disease in allogeneic bone marrow transplantation. Transplantation. 1986 Nov;42(5):558–560. [PubMed] [Google Scholar]
  26. Perreault C., Pelletier M., Landry D., Gyger M. Study of Langerhans cells after allogeneic bone marrow transplantation. Blood. 1984 Apr;63(4):807–811. [PubMed] [Google Scholar]
  27. Picker L. J., Michie S. A., Rott L. S., Butcher E. C. A unique phenotype of skin-associated lymphocytes in humans. Preferential expression of the HECA-452 epitope by benign and malignant T cells at cutaneous sites. Am J Pathol. 1990 May;136(5):1053–1068. [PMC free article] [PubMed] [Google Scholar]
  28. Picker L. J., Terstappen L. W., Rott L. S., Streeter P. R., Stein H., Butcher E. C. Differential expression of homing-associated adhesion molecules by T cell subsets in man. J Immunol. 1990 Nov 15;145(10):3247–3255. [PubMed] [Google Scholar]
  29. Reinsmoen N. L., Kersey J. H., Bach F. H. Detection of HLA restricted anti-minor histocompatibility antigen(s) reactive cells from skin GVHD lesions. Hum Immunol. 1984 Dec;11(4):249–257. doi: 10.1016/0198-8859(84)90064-8. [DOI] [PubMed] [Google Scholar]
  30. Rozman C., Mascaró J. M., Grañena A., Palou J., Feliu E., Castel T. Ultrastructural findings in acute and chronic graft-vs-hos reaction of the skin. J Cutan Pathol. 1980 Dec;7(6):354–363. doi: 10.1111/j.1600-0560.1980.tb01209.x. [DOI] [PubMed] [Google Scholar]
  31. Sale G. E., Lerner K. G., Barker E. A., Shulman H. M., Thomas E. D. The skin biopsy in the diagnosis of acute graft-versus-host disease in man. Am J Pathol. 1977 Dec;89(3):621–636. [PMC free article] [PubMed] [Google Scholar]
  32. Santamaria P., Boyce-Jacino M. T., Lindstrom A. L., Rich S. S., Faras A. J., Barbosa J. J. Alloreactive T cells can distinguish between the same human class II MHC products on different B cell lines. J Immunol. 1991 Mar 15;146(6):1822–1828. [PubMed] [Google Scholar]
  33. Schattenberg A., De Witte T., Preijers F., Raemaekers J., Muus P., Van der Lely N., Boezeman J., Wessels J., Van Dijk B., Hoogenhout J. Allogeneic bone marrow transplantation for leukemia with marrow grafts depleted of lymphocytes by counterflow centrifugation. Blood. 1990 Mar 15;75(6):1356–1363. [PubMed] [Google Scholar]
  34. Schild H., Rötzschke O., Kalbacher H., Rammensee H. G. Limit of T cell tolerance to self proteins by peptide presentation. Science. 1990 Mar 30;247(4950):1587–1589. doi: 10.1126/science.2321019. [DOI] [PubMed] [Google Scholar]
  35. Sims J. E., Tunnacliffe A., Smith W. J., Rabbitts T. H. Complexity of human T-cell antigen receptor beta-chain constant- and variable-region genes. Nature. 1984 Dec 6;312(5994):541–545. doi: 10.1038/312541a0. [DOI] [PubMed] [Google Scholar]
  36. Sviland L., Pearson A. D., Green M. A., Eastham E. J., Malcolm A. J., Proctor S. J., Hamilton P. J. Expression of MHC class I and II antigens by keratinocytes and enterocytes in acute graft-versus-host disease. Newcastle Bone Marrow Transplant Group. Bone Marrow Transplant. 1989 May;4(3):233–238. [PubMed] [Google Scholar]
  37. Verdonck L. F., de Gast G. C., van Heugten H. G., Dekker A. W. A fixed low number of T cells in HLA-identical allogeneic bone marrow transplantation. Blood. 1990 Feb 1;75(3):776–780. [PubMed] [Google Scholar]
  38. Viale M., Ferrini S., Bacigalupo A., Biassoni R., Marmont A., Nicolin A. Phenotypic and functional characterization of T cell clones following allogeneic bone marrow transplantation. Transplantation. 1989 May;47(5):838–843. doi: 10.1097/00007890-198905000-00018. [DOI] [PubMed] [Google Scholar]
  39. van Els C. A., Bakker A., Zwinderman A. H., Zwaan F. E., van Rood J. J., Goulmy E. Effector mechanisms in graft-versus-host disease in response to minor histocompatibility antigens. I. Absence of correlation with cytotoxic effector cells. Transplantation. 1990 Jul;50(1):62–66. doi: 10.1097/00007890-199007000-00011. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES